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Heat transfer from nanoparticles for targeted destruction of infectious 
organisms 
Whereas the application of optically- or magnetically-heated nanoparticles to 
destroy tumors is now well-established, the extension of this concept to target 
pathogens has barely begun. Here we examine the challenge of targeting 
pathogens by this means and, in particular, explore the issues of power density 
and heat transfer. Depending on the rate of heating, either hyperthermia or 
thermoablation may occur. This division of the field is fundamental and implies 
very different sources of excitation and heat transfer for the two modes, and 
different strategies for their clinical application. Heating by isolated nanoparticles 
and by agglomerates of nanoparticles is compared: hyperthermia is much more 
readily achieved with agglomerates and for large target volumes, a factor which 
favors magnetic excitation and moderate power densities. In contrast, destruction 
of planktonic pathogens is best achieved by localized thermoablation and very 
high power density, a scenario that is best delivered by pulsed optical excitation.  




The use of an elevated temperature to destroy pathogens has been on a firm scientific 
footing since the pioneering work of Louis Pasteur in the mid-Nineteenth Century. 
However, the industrial process of pasteurization sterilizes almost everything 
– pathogen or not – in the material that it is applied to. It is only comparatively recently 
that strategies for selectively applying heat to a specific target cell or organism have 
been identified. If this can be done efficiently, then destruction would be localized at the 
position of a target cell or pathogenic organism and collateral damage to the patient’s 
healthy cells would be minimized. Although several strategies have been considered, 
the idea of targeting a micro- or nanoparticle to the infectious organism, followed by 
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coupling of an external energy source with the particle, is probably receiving the most 
attention. Essentially the external source of energy can be light or other electromagnetic 
radiation, an oscillating magnetic field, ultrasound, or an electric field or current. 
Depending on the rate and the intensity of the heating, there are two basic outcomes: 
hyperthermia (increase in local temperature of a few tens of degrees Celsius) and 
thermoablation. The latter may also involve thermolysis: fragmentation or 
decomposition of the nanoparticle due to it reaching an extremely high temperature. Of 
course, if a particle is used then it must be non-toxic, and it should somehow be 
invisible to the patient’s immune system. There are significant challenges in the field [1, 
2, 3, 4, 5] but the first clinical use of magnetic hyperthermia has begun [6, 7]. 
Here we will consider a narrow aspect of the topic: the coupling of the external 
energy source to the nanoparticles, and the subsequent transfer of heat from them to 
target organisms. The question that we address is how best to achieve the destruction of 
pathogens, especially planktonic pathogens, using currently available sources of 
excitation. Nanoparticles are usually defined as particles in the 1 to 100 nm size range 
[8]. They are attractive for targeted hyperthermia because they have an ability to 
penetrate deeply into tissue or organisms. Although heat can also be generated by so-
called fine particles (which are in the 100 nm to 2500 nm range [8]), we confine our 
analysis in the present paper to nanoparticles due to their more penetrating nature and 
the readiness with which they can be chemically functionalized. We do not address the 
methods by which the nanoparticles can be targeted to the pathogen as this topic has 
been extensively covered elsewhere. Suffice it to say that there is a variety of active 
(e.g. antibody functionalization) or passive (e.g. extravasation) targeting schemes that 
are receiving attention [9] and, for tumors, direct injection is also a possible strategy [1, 
2]. However active targeting would be the best method to use against a mobile 
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infectious organism. We note that most of the nanoparticle/ hyperthermia literature 
relates to the potential treatment of cancer whereas reports of targeting infectious 
pathogens this way [10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23] are relatively 
scarce. Nevertheless, the physical principles involved in the hyperthermal treatment of 
either are the same, so the cancer work remains broadly relevant within the framework 
of the present paper. The main differences are that, in the case of pathogens,  there are 
fewer options for targeting and destruction may require a higher temperature than for 
cancerous cells [11, 12, 17], thus, as we show here, the optimal power densities required 
are orders of magnitude greater. Targeting infectious pathogens is, therefore, a 
comparatively challenging endeavor. 
The following sections begin by reviewing mechanisms for energy capture by 
nanoparticles. We show that light and alternating magnetic fields offer different but 
complementary opportunities. Next, the heat transfer into surrounding tissue is analyzed 
and compared for isolated nanoparticles and agglomerates. It is found that extremely 
high power densities are required to raise isolated nanoparticles to useful temperatures. 
Special attention is given to the prospect of using gold nanoparticles for hyperthermia 
via optical excitation. This is due to the special optical properties and chemical nobility 
of these particles. Finally, merits of optical and magnetic excitation to target pathogens 
are compared and it is demonstrated that, whereas large tumors can be readily targeted 
using either light or magnetic fields, planktonic pathogens can only be targeted using 
light due to the very high power input required. 
Energy capture by nanoparticles 
Two methods of generating heat in nanoparticles are receiving the bulk of current 
interest. These are optical excitation and magnetic excitation. The principle behind each 
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type of excitation will be briefly explained and their use in therapeutic contexts 
summarized. In addition, it has been reported that heat can also be generated in gold 
nanoparticles and carbon  nanotubes by application of shortwave radiofrequencies [2] or 
in gold nanoparticles by radiofrequency magnetic induction [24] whilst magnetically-
induced mechanical oscillations in suitable particles can also disrupt target cells [25]. 




When a photon of light strikes a nanoparticle (or indeed any substance), it may be 
absorbed, transmitted or scattered. Energy must be conserved so that the total energy of 
the incoming light equals the sum of the energies of the transmitted, absorbed or 
scattered light. It is the absorbed light that is converted to heat and hence of interest 
here. For exploitation of this principle in hyperthermal medicine, the ideal nanoparticle 
should possess strong absorption at a suitable position in the electromagnetic spectrum, 
and it should, of course, be biocompatible. Given these constraints, gold nanoparticles 
are widely believed to be the best candidate for hyperthermia by optical excitation.   
Spherical gold nanoparticles undergo an electromagnetic resonance with light 
which produces a strong absorption peak due to a localized surface plasmon resonance 
(LSPR). This is at about 520 nm (green light) which corresponds to the middle of the 
visible range. A relatively low power laser with emission matched to this peak could be 
a suitable source of energy. Unfortunately, the human body is not particularly 
transparent to green light so any clinical exploitation of isolated spherical gold 
nanoparticles is restricted to very shallow depths into tissue.  
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The optimum range of wavelengths for clinical exploitation of optically-excited 
heating is 670 to 890 nm, the so-called ‘tissue window’ or ‘NIR window’ [26] but, 
unfortunately, isolated spherical gold nanoparticles have a negligible optical absorption 
cross-section over these wavelengths. There are two solutions to this problem. The first 
is to make use of specialized gold nanoparticles that have shapes with LSPRs that do 
fall within the tissue window. Gold nanoshells [27] and gold nanorods [28] are probably 
the best-known examples of these. The relative merits of these two shapes have been 
explored elsewhere [29, 30]. Other specialized shapes that are also capable of 
undergoing LSPRs in the tissue window include gold nanocubes, triangles, so-called 
nano-stars, and similar geometries of lower symmetry. In all cases, the wavelength at 
which the LSPR occurs can be adjusted by modification of the geometry of the particle. 
An alternative strategy, but less common, is to use gold nanospheres, but to exploit the 
red-shifting of their LSPR that occurs when they form closely-packed agglomerates or 
aggregates [14]. (It is recommended that the term ‘agglomerate’ be used for clusters of 
nanoparticles that are weakly and reversibly bound by van der Waals or similar 
secondary bonds, and ‘aggregate’ be used for clusters of nanoparticles that are 
irreversibly bound together by primary chemical or metallurgical bonds [8].) Either way 
(whether lower symmetry particle or agglomeration of spheres) significant optical 
absorption can be developed at wavelengths that are within the tissue window. The 
LSPR peak associated with such agglomerated entities is broad but this is not a problem 
in the context of a hyperthermal therapy delivered with a monochromatic light source.  
Applications in hyperthermia 
Gold nanoshells have received considerable attention in this regard and clinical trials for 
head and neck tumors, prostate tumors, lung tumors, breast cancer, oropharyngeal 
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malignancies and acne have been mooted or initiated [2, 31, 32, 33, 34, 35]. However, 
there have been relatively few recent scientific reports so far on the outcomes of these 
trials. Preclinical studies involving nanorods are also frequently reported in the 
scientific literature, again usually with some cancer as the target, for example refs. [36, 
37]. As mentioned above, application of these principles to target infectious organisms 
is far rarer, but, for example, successful in vitro trials of the efficacy of gold 
nanospheres and nanorods  against the tachyzoite phase of the protozoan Toxoplasmosis 
gondii [11, 14] or of gold nanospheres against the bacterium Staphylococcus aureus 
[10] have been reported. 
Biocompatibility 
Gold is the most commonly used material for these types of applications, due to its 
biocompatibility [32] and good optical properties. In contrast, while silver actually has 
significantly better optical properties for these types of plasmonic applications, 
especially in the visible part of the spectrum, it is susceptible to corrosion. The 
difference in the optical properties of gold and silver reduces as the excitation 
wavelength lengthens into the tissue window and the near-infrared [38], a factor which 
also favors the use of gold.  
In conclusion, it is evident that gold offers a suitable combination of chemical 
and optical properties for light-induced hyperthermia. 
Magnetic excitation 
Principle 
Heat may be generated by applying an oscillating magnetic field to either ferromagnetic 
or superparamagnetic nanoparticles, however there are many advantages to using the 
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latter [39]. Like gold nanoparticles, the magnetic nanoparticles can be small and 
penetrating, can be chemically functionalized, and can be modified by control of their 
geometry. In addition, superparamagnetic nanoparticles also have the property that they 
can in principle be guided and heated by an external magnetic field, but that their net 
magnetic moment vanishes when the field is turned off, which is advantageous.  
Superparamagnetism is a phenomenon that only occurs for small particles which 
possess locally ordered spin structure but have a low volume to give the distinctive 
magnetic properties illustrated in Figure 1, notably a strongly frequency-dependent 
magnetic response concurrent with the absence of permanent static magnetization. The 
low volume of a nanoparticle means that the energy barrier separating each of the 
degenerate magnetic states is small compared to the thermal energy provided by heat. 
Thus in the absence of an external field, the nanomagnet undergoes Néel relaxation via 
continuously flip-flopping between the two states with a characteristic relaxation time 
given by [40]:  
   =   .      
∆ 
   
                                         (1) 
The magnetic relaxation time is determined by the size of the energy barrier 
∆ ~  that is proportional to the volume of the nanoparticle (V) and the intrinsic 
crystalline anisotropy of the magnetic crystal lattice (K). For nanoparticles suspended in 
fluid, Brownian motion of the surrounding fluid introduces additional reorientation 




                                   (2) 
, involving biological factors, including the dynamic viscosity of the fluid   and the 
effective hydrodynamic diameter of the nanoparticle after opsonization (V) [41]. 
According to the equation from Shliomis [42], the total relaxation time is: 
  =  
    
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At sufficiently high temperature (above the ‘blocking temperature’), the relaxation 
between the states is so frequent that on average no magnetization appears in a 
thermalized particle ensemble. It conveniently turns out that many nanosized materials 
remain in the superparamagnetic state even at room temperature. This unique feature of 
superparamagnetism accounts for the coexistence of high magnetization with the 
absence of remnant (permanent net magnetization) because the system undergoes a 
time-dependent relaxation towards zero average magnetization after the external field is 
removed. The low mass/high magnetization allows small concentrations of 
nanoparticles to yield appreciable effects in the body. The absence of permanent 
magnetism is an advantage because otherwise magnetized particles tend to interact and 
agglomerate even in the absence of a field due to dipolar interactions, limiting their 
blood half-life and biomedical applications.   
In the presence of an alternating field, magnetic nanoparticles will attempt to 
align their magnetic moment with the applied field. Associated with this magnetic 
reversal, there is an energy cost with irreversibilities leading to power dissipation in the 
form of heat. For hyperthermia, it is important that the magnetic material contains some 
degree of hysteresis in order to generate heat losses to the AC field. The increase in 
internal energy  is [41, 43]: 
∆  = −   ∮  ( )         (2) 
per cycle, where H is the magnetic field intensity, M(t) is the dynamic magnetization, 
and the integral is performed over a single cycle of the field. Power dissipation at a 
frequency f is given by 
  =  . ∆  =     ∮  ( )        (3) 
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The integrated term is proportional to the area enclosed by the  M vs H 
hysteresis curve [40]. For a superparamagnet, this can be related to the out-of-phase 
dynamic susceptibility and is strongly dependent on the AC frequency because the 
integral involving M(t) is frequency dependent as it involves the superparamagnetic 
relaxation processes. 
Applications in hyperthermia 
Hypothermia or pasteurization using magnetic particles has a long history: the concept 
was mentioned in  a paper by Goldenberg and Tranter in 1952 [44]and tested on tumors 
in dogs by Gilchrist in 1957 [1]. Renewed interest appeared from the 1980s with 
numerous groups investigating smaller particles coated for increased biocompatibility. 
Superparamagnetic iron oxides, Fe3O4 and -Fe2O3, remain the material of choice. 
Many preclinical studies have shown that positive temperature differences can be 
induced between tumors and normal tissue, however, there are also reports claiming that 
useful results can be obtained even if a positive temperature difference cannot be 
measured, so-called “cold hyperthermia” [5, 45, 46]. This implies a more localized 
mechanism of action than whole-tumor hyperthermia in these cases.  
Despite the widespread preclinical interest, relatively few clinical trials have 
been reported, so far.  The examples known to the authors include investigations of the 
use of magnetic particles against glioblastoma multiforme, and prostate and pancreatic 
cancer [5, 47]. Some commercial clinical exploitation has recently begun in the 
European Union [6]. 
Biocompatibility 
Currently only the iron oxides are approved for human usage because of their known 
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metabolic pathways. There would be numerous advantages to using more typical 
ferromagnetic metals such as nickel, cobalt and Ni80Fe20 since these materials tend to 
have higher magnetization. On the other hand, such materials are carcinogenic or toxic, 
and would need to be insulated from the body by the use of a surface coating of gold or 
a polymer. While such approaches are certainly feasible, there is no horizon for the 
approval of such materials in clinical trials.  
 
Methods for analyzing local heating from a nanoparticle 
There have been a number or prior studies in which the heat transfer from particles or 
nanoparticles has been examined (see, for example, refs. [41, 48, 49, 50, 51, 52, 53, 54, 
55, 56, 57, 58]. There are, however, many important differences between the 
assumptions made in these studies and in the scenarios in which clinicians might wish 
to apply hyperthermia or thermoablation. In the present paper we focus on answering 
the question of how best to deliver a useful degree of hyperthermia or thermoablation to 
a pathogen.  
In general, the transfer of energy from the heated zone to the surrounding 
medium may be handled in two ways, either by assuming transfer by conduction or by 
convection. In the case of photothermolysis, radiative heat transfer could also be 
considered due to the very high temperatures reached by the particle. Somewhat 
different analytical forms result, with the assumption of the conduction case generally 
providing the faster rate of heat transfer since there is no boundary layer to retard heat 
flow [59]. 
The temperature of a nanoparticle and the flow of heat outwards into the 
surrounding fluid or other thermally conductive medium can be modelled using the 
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analytical expression of Goldenberg and Tranter [44], which, interestingly, was derived 
in 1952 to support early studies into radiofrequency-assisted pasteurization and 
sterilization, or it can be modelled by more tractable expressions due to Pustovalov [51]. 
The latter predict a slightly more rapid rate of heating within the nanoparticle than does 
the former due to slightly different assumptions having been made in its derivation, 
however outside of the heated sphere, the temperature distribution of the two solutions 
is effectively identical. In both cases, the models consider certain biological factors such 
as the thermal conductivity of the surrounding tissue, bones or fat. On the other hand, 
certain factors such as vascularization and multiple diffuse interfaces are simplified or 
ignored, so at best the models provide an upper limit on the heating. It is convenient to 
use the G&T equations when energy input is expressed in W/m3 and the Pustovalov 
ones when energy is expressed in W/m2 of flux. Both assume conductive heat transfer 
so are likely to slightly overestimate the cooling rate. In addition, the analytical solution 
for transient convective heat transfer from a sphere [60] will be used here to estimate 
cooling after the excitation is terminated. 
In the case of optical excitation, the power captured by an isolated nanoparticle 
that is undergoing a localized plasmon resonance is 






 dECQ abs         (4) 
where 

Q  is the heat transfer rate (watts), Cabs() the wavelength-dependent absorption 
cross-section, E() is the spectral irradiance of the light source (W.m-2.nm-1), and 1 and 
2 (nm) are the limiting wavelengths of light over which the light source operates [54]. 
Cabs() is readily available for arbitrary shapes by calculation [61]. For illustrative 
purposes, a gold nanoparticle of 30 nm diameter will generate 1.410-9 W when 
irradiated with a 100 mW laser of 0.5 mm diameter under conditions where Qabs = 4. 
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Modelling the heat capture from the intrinsic magnetic properties of materials, 
by contrast, is more difficult because of the frequency-dependent susceptibility, and lies 
outside of the scope of the present paper. Generally, a measured value may be used for 
first-order estimates; for example data provided in a recent publication [45] may be used 
to provide an estimate of 5 10-13 W per oxide nanoparticle of 66 nm diameter when it 
is excited in  a typically applied magnetic field of 10 kA/m at about 900 kHz. 
Finally, a note on the units for power. The excitation power can be expressed in 
W/m2 if the particle is considered to lie in an excitation field and have a capture cross-
section (in physical units of area) with dimensionless efficiency . The captured power 
may also be parameterized as W/m3 relative to the active volume that is undergoing 
excitation. These parameters can be converted into one another by appropriate 
manipulation. The fluence delivered is obtained by multiplying the power by the time it 
is applied, and can similarly be presented per unit area or per unit volume, whichever is 
the more convenient. 
Heat transfer to the surrounding tissues: localized pasteurization versus 
thermoablation  
For the purposes of targeting and destroying pathogens via nanoparticle heating, it does 
not matter whether the energy was initially supplied by optical or magnetic excitation, 
the end result will be the same provided that the tissue surrounding the target is 
transparent to the laser wavelength used. In both cases the objective is usually to raise 
the temperature of the target cell or organism to a level at which apoptosis or direct 
necrosis occurs while avoiding damage to the surrounding tissue. Temperatures 
upwards of about 42 °C are required, and of course higher temperatures are better [2].  
It is, however, useful to draw a distinction between two rather different modes of action: 
local pasteurization and thermoablation. In the temperature range 43 to 50°C range, 
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apoptosis is the likely outcome, but extensive protein denaturing and necrosis will result 
as temperatures rise towards the boiling point of water.  We will group both of these 
phenomena together here as ‘localized pasteurization’. In contrast, in an alternative 
strategy, the temperature of the nanoparticle is raised so high (>2000°C) that it 
fragments and generates a steam shockwave, thereby perforating a nearby cell 
membrane or cell wall by mechanical means [10, 62, 63]. This latter mechanism has 
been termed ‘photothermolysis’ [64] if generated by light.  Thermolysis can only be 
achieved by a rate of heating that is so fast that the nanoparticle can effectively be 
treated as an adiabatic system. Since (as we will see later) heat transfer from particle to 
environment takes place on a time scale of a few nanoseconds, exploitation of 
photothermolysis requires that the fluence is delivered in even shorter pulses. 
The isolated particle scenario is not particularly effective for local pasteurization 
as heat transfer out from such a particle is exceedingly rapid which hinders a high local 
temperature from being achieved [49, 58]. In fact, it is usually much better to deploy a 
multiplicity of particles to the vicinity of the target cell or organism in order to deliver a 
lethal dose of thermal energy [52], however the optical properties of agglomerates are 
quite different from those of individual isolated particles. Therefore, we will divide the 
discussion below into two threads, corresponding to heating from isolated nanoparticles 
and from agglomerated clusters of nanoparticles. 
Heat generation by isolated nanoparticles 
Our analysis does not depend on the source of the applied thermal energy (optical, 
magnetic etc.) but for simplicity we will use the language appropriate to the case of 
optical excitation in the discussion that follows. 
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 In broad summary, the local region over which the elevated temperature is 
obtained is very limited in the case of individual small, spherical heat sources. Some 
illustrative results of calculations for nanoparticles immersed in water are shown in 
Figure 2. In Figure 2(a) we show an illustrative calculation for a medium power pulsed 
excitation (1109 W/m2). It should be noted that the volume of surrounding medium 
that is heated into the hyperthermia range is very small, only 3.110-5 m3 if the 
threshold temperature is set at 50°C. Isolated particles will be ineffective in this 
scenario. In contrast, in Figure 2(b) we show the temperature distribution that can be 
reached when the nanoparticle is excited at a relatively high power, chosen here as 
1.61011 W/m2 so that the boiling point of gold is attained.  There is still a very steep 
fall in temperature with distance from the nanoparticle, but the volume of surrounding 
medium that is heated to at least 50°C is much larger, at 128 m3. Naturally, this is an 
example of the thermolysis mode so there will additionally be mechanical damage to 
nearby cells due to shock and/or physical perforation by gold fragments.  
The rate and duration of heating is a very important factor. Consider the case for 
a plasmonically-heated nanoparticle. When a single photon of the resonant frequency is 
absorbed by the nanoparticle, it generates a distribution of hot electrons in about 5 fs 
(510-15 seconds). The hot electrons couple to the lattice and relax to generate or 
amplify lattice phonons over the next ~5 ps (5 10-12 s). In effect, phonon vibrations are 
the main manifestation of the kinetic energy that determines the “temperature” of the 
nanoparticle from the perspective of heat transfer.  At this point the heating has been 
essentially adiabatic, i.e. little energy has been transferred yet to the medium 
surrounding the nanoparticle. Over the next 10 to 100 ps the heat flows out to the 
environment and after about 400 ps the nanoparticle temperature is the same as that of 
its adjacent medium. The only exception will be if the particle is struck by an intense 
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pulse of coherent photons (for example by a laser), in which case the initial temperature 
rise may be so high as to vaporize the nanoparticle and thereby cause a 
photothermolysis shockwave.  In contrast, if the intensity of the pulse is low then the 
small amount of heat delivered is rapidly transferred away into the surrounding medium 
with little effect. In this case prolonged illumination and/or a high density of 
nanoparticles is required to achieve localized pasteurization. 
Clearly, the only way that isolated nanoparticles can be effective in vivo is in 
thermolysis mode. The question then becomes: how many cell membranes or wall 
perforations are required to cause necrosis?  Pitsillides et al.[62] note that a cell’s 
natural repair processes will heal perforations over a time scale of a few minutes. The 
damage induced by the photothermolysis must accumulate faster than the rate of repair 
or else it will recover. In addition, different components of a cell (e.g. membrane, 
nucleus) will have different tolerance to damage. It is important to note that 
(photo)thermolysis mode can be effective at relatively low energy inputs (of the order of 
0.025 to 0.5 J/cm2 [10, 62, 63, 65]) provided that the laser pulse power is very high. 
This is because the effect is extremely local and the destructive process is achieved at 
the nanoscale before the energy is thermally dissipated into the surrounding medium 
[63]. In contrast, at least 1 J/cm2 is normally required [65]  for slower modes of heating. 
In general a safety threshold of 0.1 J/cm2 has been set for medical lasers [63], so clearly 
the lower fluences associated with photothermolysis are potentially advantageous. 
The FDA have imposed limits of ~3 W/kg on heating due to magnetic fields in 
MRI devices and there is also a view that the product of frequency and alternating 
magnetic field amplitude should be less than somewhere between 0.5109 and 5109  
A-turns/(m.s) in order to prevent stimulation of nerves or undesirable eddy currents  [5, 
66]. In practice, however, only a few hundred W/g is available from magnetic 
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nanoparticles anyway using standard AC fields [58, 66] and so the power required to 
destroy a pathogen, small cluster of cells or even small tumors cannot be achieved [58]. 
In contrast, exploitation of optical excitation allows for greater heating power, for 
example as in ref. [62].  
As mentioned, one issue with spherical gold nanoparticles is that their plasmon 
resonance wavelength lies well outside of the tissue window range. The problem can be 
addressed by using a shape such as the nanoshell or the nanorod. The optical absorption 
cross-sections for nanospheres of 15 nm diameter (a typical size for particles produced 
by the citrate [67] route) and gold nano-dogbone of 45.6 nm length, 22.5 nm diameter at 
mid-section are shown in Figure 3. (This latter shape can be produced by the 
silver/CTAB route [68]). We use it here merely as an illustrative example of the many 
gold nano-shapes that can exhibit a localized plasmon resonance within the tissue 
window.) 
The thermal stability of isolated gold nanoparticles must also be considered. 
There will be a strong tendency for the gold shapes to coalesce into solid spheres under 
the action of the intrinsically high surface tension of gold, especially when heated by a 
laser of a resonant wavelength [69]. Change in shape, for example from a rod to a 
sphere, will cause the resonant wavelength of the gold particle to blue-shift, away from 
the tissue window and possibly away from the excitation wavelength(s) used. This is a 
thermally-activated process so that it will be exacerbated by higher temperatures and/or 
longer times. This places limits on the temperature and time-at-temperature that a gold 
nanorod, nanocage, nanoshell etc can be exposed to. Clearly, in individual particle 
mode, these special shapes would be best used in low-temperature hyperthermia mode 
(for which prolonged exposure is feasible) or in a once-off photothermolysis shot 
(which will destroy the shape of the nanoparticles). This limitation is less applicable to 
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solid gold spheres (since they are already in their most stable shape) although it should 
be noted that there will be some changes in the optical properties of gold due to lattice 
expansion and electron scattering as it heats up [70].  
Heat generation by agglomerates of nanoparticles 
The previous section highlighted the challenges of using isolated or dilute 
concentrations of nanoparticles for hyperthermia. On general grounds, many of these 
limitations can be overcome if agglomerates of many nanoparticles are used instead 
because local heating effects will, on balance, be increased. This is despite the fact that 
agglomeration induced by biological factors will decrease per particle heating efficiency 
due to changes in capture cross-section and, in the case of magnetic excitation, to 
changes in local viscosity [41].There is, however, no simple analytical solution for the 
heat transfer in this situation. The optical extinction cross-section of a specific 
arrangement of particles may be numerically calculated using the discrete dipole 
approximation mentioned previously but some simplifying assumptions are normally 
made for the heat transfer. The dimensionless optical extinction efficiency of an 
agglomerate is generally inferior to that of a single nanoparticle, but the key point is that 
the absorption cross-section in physical units is much larger. In addition, the peak 
extinction is red-shifted, possibly into the tissue window. For the case of gold 
nanospheres, this is a distinct advantage as it permits excitation at wavelengths at which 
they would otherwise be nearly transparent [14, 71, 72, 73, 74].  The situation is 
compared in Figure 4 for an isolated gold nanosphere and an agglomerate.  
It is clear that the formation of the agglomerate has created optical absorption 
within the tissue window. In addition, the optical or magnetic properties of 
agglomerates are not especially sensitive to how many particles are involved once some 
19 
 
threshold (about ten) has been exceeded so the actual configuration of the agglomerated 
particles is not very important. 
Of course agglomerates of magnetic nanoparticles can also be heated.  
Regardless of the source of excitation, an agglomeration of nanoparticles generates a 
volume of local heating, with each nanoparticle shedding heat into a warming volume. 
In practice, this strategy is attractive, as agglomerations of nanoparticles on or in a 
target organism or cell can be readily accomplished by some kind of chemical targeting 
or, in the case of macrophage targets, by the process of endocytosis [75]. Indeed, 
agglomeration of nanoparticles is the expected behavior in physiological fluids unless 
great care is taken to prevent it.  
The heat transfer problem for agglomerates can be solved, at least to a first-order 
approximation, by allowing all absorbed energy to heat the local spherical volume of 
water that just envelops the agglomerate, and then estimating the transfer of that heat 
outward to the surrounding medium which does not contain any nanoparticles. 
Examples of this approach may be found in the literature [50, 57, 76]. Here we will term 
the volume of material that contains the nanoparticles the active volume, to differentiate 
it from the surrounding medium which does not contain any source of heat. (The same 
equations used for an isolated spherical nanoparticle can be used for a spherical active 
volume but with internal heat generation assumed to be homogeneous. The power input 
must be rescaled according to the density of nanoparticles present and the thermal 
conductivity and diffusivity of the active volume can be approximated with the values 
for water or human tissue.)   
The active volume will begin to shed heat to the surrounding medium as soon as 
it starts to heat up. The temperatures that can be reached depend on the rate of heating 
within the active volume, on the magnitude of the heat transfer coefficient that moves 
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the heat out of the active volume into the surrounding medium, and, very pertinently, on 
the volume of the active region. Generally, however, it is assumed in the agglomerated 
particle scenario that the thermal payload needs to be delivered within the active volume 
or very close to it. In this paradigm the temperature outside of the active volume is of 
little importance provided that it is low enough to prevent collateral damage to the 
patient’s healthy tissues.  
An illustrative analysis for the case of laser heating is shown in Figure 5. An 
analogous analysis would apply in the case of heating by an agglomeration of magnetic 
particles within a fluctuating magnetic field. In either case, the active volume is heated 
by a continuous excitation (laser or magnetic field) of an intensity that will bring it to, 
for example, 80°C. The active volume is simultaneously being cooled by a combination 
of conduction and convection. Only energy deposited in the active volume is taken into 
account here so the actual energy flux applied may need to be larger than the values 
shown. In the following analysis both active volume and surrounding fluid are assumed 
to have the heat transfer properties of water. The equations of Pustovalov [51] have 
been used.  
Two clinical situations are considered: destruction of a labile pathogenic 
organism of about 10 m diameter to which an active volume  has been attached, and 
destruction of solid tumor of 10 mm diameter that has been infiltrated somehow with 
nanoparticles (for example by extravasation or direct injection) so that the entire tumor 
is actually the active volume. From Figure 5(a) it is clear that the tumor can be heated 
with relatively modest power input whereas an appreciably more intense excitation is 
required to maintain the temperature of the much smaller active volume attached to a 
pathogen. In the latter case, convective heat transfer out of the active volume is 
extremely rapid due to its greater ratio of surface area-to-volume, and this is why the 
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much higher power input is required to maintain the temperature. Note, however, that a 
significantly smaller dose of energy is delivered in the case of the ‘pathogen scenario’ 
owing to the smaller active volume. For example, if the two scenarios are compared at 
100 seconds, a single active volume in the pathogen scenario has delivered only 1.610-
2 J of thermal energy. Of course, there would be many pathogens and hence many active 
volumes in the putative anti-pathogen hyperthermia. The actual total thermal energy 
delivered would depend on the number of active volumes within the region of 
excitation. If, for example, the excitation volume contained 100,000 active volumes 
then the total energy delivered would be much larger (1620 J). By comparison, in the 
case of the tumor only 162 J would have been delivered.  The very high powers and 
energy inputs needed for the ‘pathogen’ or ‘isolated particle’ scenarios are the result of 
the very rapid heat transfer from nano- or micron-sized particle or active volumes. This 
is particularly evident if cooling following termination of the external excitation is 
considered, Figure 5(b). Here a heat transfer coefficient of 50 W/m2/K has been 
assumed (i.e. corresponding to natural convection in water). Even faster cooling would 
prevail if there were vascular fluid flow adjacent to the active volume [58]. 
Discussion: options for treating pathogens 
As shown here and by others [49, 58], hyperthermia of dispersed or planktonic 
pathogens using magnetic excitation of isolated nanoparticles would appear to be 
impractical as negligible heating would be generated, even by reasonably strong 
alternating fields. This is due to the way heat transfer rates scale with specific surface 
area, and to the limited amount of energy that can be input using an alternating 
magnetic field. Indeed, even pathogen-sized active volumes containing agglomerates of 
magnetic nanoparticles cannot be heated to temperatures high enough to kill pathogens 
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if they are planktonically dispersed.  
In contrast to the difficulty in targeting mobile pathogens using isolated 
particles, agglomerates of nanoparticles, or ‘active volumes’ containing a high density 
of nanoparticles provide a feasible strategy for pathogens due to the much greater 
heating power that is possible. The question is: how many nanoparticles are required per 
active volume at a given heating power?  It is convenient to use the analytical heat 
transfer solution provided by Goldenburg and Trantor [44] here as this is set up in terms 
of a volumetric power density. We use the typical thermal conductivity (0.48 W/m/K) 
and thermal diffusivity (1.310-7 m2/s) values for human tissue [77] for the medium and 
those of water for the active volume. We consider that heating is by gold nanospheres 
with a diameter of 30 nm and a Qext of 4. For illustrative purposes the results are 
provided for two different irradiation scenarios. These are (1) a lengthy, low power 
pulse that brings the active volume to a steady state temperature of 100 °C, which we 
designate as low-power/long-pulse (corresponding for example to a 100 mW CW laser 
focused to 0.5 mm diameter spot and 1.4410-9 W per nanoparticle) and (2) a high 
power, short pulse with a power that, if allowed to continue to steady state, would 
eventually heat the active volume to 500°C. However, in our scenario this excitation is 
only applied long enough to bring the active volume to 100°C and is then terminated. 
We designate this as high-power/short-pulse. (This is obtainable from a pulsed laser 
excitation of user controllable duration and power. Since, as we will show, the fluence 
is much reduced under this scenario, it is permissible to apply the excitation at a higher 
power. Here we imagine the use of a laser of 10 W power applied to a spot of 0.5 mm 
diameter so that we get 1.4410-7 W per nanoparticle). In both cases an active volume 
of the diameter indicated on the horizontal axis is considered, and the number of 
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nanoparticles per active volume that are required to reach 100°C under the two 
scenarios plotted.  
As is already well-known [49, 58], it is trivial to obtain the 100°C in a large 
volume similar to that of a tumor, but it is more difficult to reach 100°C for pathogen-
sized active volumes. Note also, that there is a geometric packing limit on how many 
individual nanoparticles can be closest-packed into an active volume. This constrains 
the power that can be produced for very small active volumes. For the conditions 
applied here, the high-power/short-pulse scenario is more attractive as it reaches 100°C 
in smaller active volumes and with fewer gold nanospheres than the alternative 
scenario, Figure 6(a). The fluence, or total thermal energy delivered, is the other factor 
to consider. This energy will be passed outwards to the surrounding tissue and should be 
strictly limited to prevent unnecessary collateral damage. If the active volume has a 
diameter of 1 m then it takes 0.2 s to bring it to 100 °C in the low-power/long-pulse 
scenario but only 1.410-7 s in the high-power/short-pulse scenario. There is 
correspondingly a much lower fluence in the latter case notwithstanding the higher 
power delivered. The fluences delivered in the two scenarios are compared in Figure 
6(b).   
 Thus far we have addressed only the two cases at opposite extremes of the 
hyperthermia spectrum, namely destroying macroscopic tumors or microscopic 
planktonic pathogens.  The key insight is that very high power density is required to 
destroy the latter. Of course, there are other scenarios. For example, pathogens may 
infect localized areas such a bone, the surfaces of implants, or wounds. In these 
instances it would be feasible to concentrate the nanoparticles at the site of infection 
and, importantly, heat transfer in these cases may be constrained in some directions. 
This latter factor would lower the power density required to cause successful targeting. 
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Indeed, viable magnetic field-induced hyperthermia has already been demonstrated in 
certain 2D configurations [78].  There is also the possibility of treating the pathogens ex 
situ. For example, the patient’s blood could be diverted to an external device in which 
the irradiation is performed. While a high power density of irradiation would still be 
required, in principle, it would be easier to control temperature in such a configuration. 
Another important point is that ex situ treatment can solve the problem of variable 
attenuation of the radiation source since the radiation path length can be kept short and 
consistent. Further research into this possibility therefore seems worthwhile. 
 
Conclusions 
It is clear that treating pathogens with nanoparticle-induced heating presents 
some unique challenges compared to the case of treating centimeter-sized solid tumors. 
The two most commonly discussed modes of excitation in this field are laser 
illumination of a plasmonically-resonant nanoparticle, or magnetic field excitation. The 
challenges are that some way must be devised to attach or assemble active volumes of 
nanoparticles on each pathogen, and that a rather higher excitation power must be used 
to maintain an effective temperature. The latter is due to the far higher ratio of surface 
area-to-volume of a pathogen compared to a centimeter-sized solid tumor. For example, 
whereas an absorbed energy of 2104 W/m2 is adequate to raise a 10 mm diameter 
tumor to 80°C,  a 1 m diameter pathogen requires 2108 W/m2 to achieve the same 
result. This latter figure is simply not available from magnetic excitation at present.  
The heat payload of a nanoparticle can be delivered in the limiting cases as 
localized pasteurization or as a thermolysis micro-explosion. While the payload can be 
delivered in principle by isolated nanoparticles using optical excitation, this would only 
be effective in thermolysis mode.  This is because in this case heating is practically 
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adiabatic due to the very short times involved and heat losses to the surrounding tissue 
can be neglected, however, very high power density is required. In contrast, heating by 
agglomerates of nanoparticles presents less demanding requirements for the excitation 
power. In the case of plasmonic-heating, allowing agglomeration of nanoparticles at the 
site of the pathogen brings the added advantage of increasing optical absorption cross-
section within the so-called tissue ‘window’.  
We defined the concept of an active volume, a volume that contains the 
agglomerated nanoparticles and which can be treated as a heat source in its own right.  
The heat transfer characteristics for active volumes containing agglomerates were 
analyzed under various scenarios. Destruction of a pathogen by means of co-located 
active volumes is viable by optical excitation of gold nanoparticles but not by magnetic 
excitation. High power pulses of light with very short duration are clearly the preferred 
option for pathogens in order to limit the total fluence delivered, for example, pathogen-
scale volumes can be raised to 100°C by a short, high power laser pulse that delivers a 
fluence of only 10-9 J per pathogen whereas a slow lower power pulse might need to be 
applied at 10-3 J per pathogen to achieve the same effect. 
Destruction of planktonic pathogens via hyperthermia, therefore, faces strong 
physical challenges, and relies on extremely high power densities. It may nevertheless 
offer a way forward for very specialized situations, for example those that cannot be 
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Figure 1. The magnetization versus field response of a superparamagnetic material at (a) 
high driving-field frequencies and (b) very low frequencies.  
 
 
Figure 2.  (a) An example of hyperthermia, obtained using a pulsed excitation intensity 
of 1109 W/m2. (b) An example of photothermolysis, obtained using a pulsed excitation 




Figure 3. Calculated optical absorption efficiencies for 15 nm diameter gold 
nanospheres and a gold nano-dogbone with aspect ratio of 2:1. 
 
 
Figure 4. Optical absorption cross-sections for an isolated gold nanosphere of 15 nm 





Figure 5. (a) Comparison of the time-temperature profiles when heating a 10 mm 
diameter tumor and a 1 m diameter active volume (labelled as ‘pathogen’). In both 
cases the excitation energy has been adjusted to give a steady state temperature of 80°C. 





Figure 6. Comparison of the low-power/long-pulse heating scenario with the high-
power/short-pulse scenario. (a) Number of nanoparticles required to achieve 100°C. (b) 
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